Browsing by Author "Abdulazeez, F. I."

Now showing 1 - 3 of 3
  • Item
    ABO/Rhesus blood group systems are not clinical indicators of male baldness
    (College of Medicine, Ambrose Alli University, Edo, Nigeria, 2017-06) Ayinde, T. O.; Ojulari, L. S.; Sanni, M. A.; Afodun, A. M.; Jimoh-Abdulghaffaar, Hidaayah Oluwamayowa; Ayinla, M. T.; Abdulazeez, F. I.; Abdulkareem, S.; Abdulraheem, H. A.; Samotu, K.
    Background: Several disease entities have been linked to the ABO/Rh blood group systems.Baldness or alopecia is the partial or complete lack of hair on the head and/or body. Major advances have been achieved in understanding principal elements of the androgen metabolism involved in the pathogenesis of alopecia, but not much preliminary work has been done in its relationship to blood types. Aim: This study is aimed to determine if there is any association between blood types and male baldness. Methods: 400 male subjects (25-60 years)at Sobi Specialist Hospital Alagbado, Ilorin, kwara State, Nigeria were recruited into the study(200 for control and 200 for baldness).Blood sample was collected from each subject for blood grouping estimation, following the completion of a questionnaire containing information about baldness and haematological profile. Result: The distribution of phenotypic frequencies of ABO group in the control samples were 26.0%, 28.0%, 4.0% and 42.0% for groups A, B, AB and O, respectively, while 92.0% of the subjects were Rh (D) positive and 8.0% Rh(d) negative. And for the baldness, they were 26.0%, 26.0%, 4.0% and 44% for A, B, AB, and O respectively; while Rh (D) positive were 94.0% and Rh (d) negative were 6.0%. The overall result is statistically insignificant (P>0.05) using Pearson Chi-square. Conclusion: The result reflects an absolute parallel relationship between baldness and ABO/Rhesus blood group systems. Thus, ordering for blood group assessment during routine hair clinic as part of ancillary investigation should be discouraged, except if other interests arise.
  • Item
    Effect of gliclazide on uric acid and C-reactive protein in alloxan-induced diabetic rats
    (Published by University of Ilorin, Ilorin, Nigeria, 2012) Ojulari, L. S.; Biliaminu, S. A.; Dangana, E. O.; Abdulazeez, F. I.; Ayinde, T. O.; Adegoke, O. A.
    global health. It contributes to oxidative stress and also induces inflammation and hence severe complications. Several drugs have been introduced so far to salvage this metabolic disease alongside its complications. Objectives: This study was designed to investigate the effects of gliclazide on serum uric acid and C-reactive protein (a biomarker of inflammation) in alloxan-induced diabetic rats. Materials and Methods: Sixteen wistar rats were divided into 4 experimental groups with four rats each; Group A-control (Drug vehicle), Group B-diabetic, Group C- diabetic/gliclazide (10mg/kg twice daily for 28days) and Group D-normal/gliclazide (10mg/kg twice daily for 28 days). At the end of the experimental period (four weeks), animals in all groups were fasted for 12 hours and blood samples were taken by cardiac puncture for determination of serum uric acid and C-reactive protein (CRP) levels. Results: The study shows no significant statistical change in the serum uric acid levels (p>0.05) when the Experimental groups were compared with the controls. On the other hand, there was significant decrease (p<0.05) in CRP levels when values in the controls were compared with diabetic treated and normal treated groups. Conclusion: This finding may suggests that gliclazide possesses cardioprotective property since CRP has been implicated in atherosclerotic changes which is a common complication of diabetes mellitus. This may be through its anti-inflammatory effect by reducing the plasma concentration of IL-6, which is produced predominantly by macrophages and so prevents diabetic complications.
  • Item
    The Effect of Metformin on Serum Levels of FSH, LH, Oestrogen and Progesterone in Diabetic Rats
    (College of Health Sciences, University of Ilorin, Ilorin, Nigeria, 2013) Ojulari, L. S.; Biliaminu, S. A.; Ahmed, T. T.; Abdulazeez, F. I.; Oyekunle, O. F.; Niyi-Odumosu, F. A.; Adegoke, O. A.
    Diabetes mellitus represents one of the greatest global health threats. It contributes to sub-fertility in females and impairs the normal menstrual cycle and ovulation. This study was designed to investigate the effect of oral administration of metformin on FSH, LH, oestrogen, and progesterone in diabetic rats. Twenty female rats were divided into four experimental groups of five rats each. Group A (control) received distilled water ad libitum. Group B were diabetic untreated; Group C received metformin only; Group D were diabetic and received metformin. At the end of the four-week treatment period, blood samples were collected for hormone assays. The results showed significant (P<0.05) reductions in FSH and LH levels in all experimental groups compared to control. Progesterone levels significantly increased in Groups B and D compared to control, while oestrogen levels were reduced in all experimental groups but insignificantly (P>0.05). The study suggests that metformin’s ovulation-inducing effect is likely due to its direct action on the ovary, and not solely due to improved insulin sensitivity.